Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the Company will hold a conference call on Wednesday, November 13, 2024, at 2 p.m. CET / 8 a.m. ET, to give an update on business progress during the third quarter of 2024.
Participants during the call will be:• Jonathan Dickinson, Chief Executive Officer• Sonia Quaratino, Executive Vice President, Chief Medical Officer• Yannis Morel, Executive Vice President, Chief Operating Officer• Frédéric Lombard, Senior Vice President, Chief Financial Officer• Arvind Sood, Executive Vice President, President of US Operations
Details for the Virtual Event:
The live webcast will be available at the following link:https://events.q4inc.com/attendee/381945831
Participants may also join via telephone using the following registration link:https://registrations.events/direct/Q4I280043.
This information can also be found on the Investors section of the Innate Pharma website,www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.
| Press release in English | 119.8 KB |
| Communiqué de presse en français | 100.87 KB |